87 related articles for article (PubMed ID: 38561745)
1. Clinical significance of LINC02532 in hepatitis B virus-associated hepatocellular carcinoma and its regulatory effect on tumor progression.
Ding W; Xi S; Gao K; Weng D; Xu S; Huang G; Yu M; Yue H; Wang J
Clin Res Hepatol Gastroenterol; 2024 Jun; ():102403. PubMed ID: 38901567
[TBL] [Abstract][Full Text] [Related]
2. Glycosylation and liver cancer.
Mehta A; Herrera H; Block T
Adv Cancer Res; 2015; 126():257-79. PubMed ID: 25727150
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects.
Kao JH; Chen PJ; Chen DS
Adv Cancer Res; 2010; 108():21-72. PubMed ID: 21034965
[TBL] [Abstract][Full Text] [Related]
4. Integrating transcriptomics, glycomics and glycoproteomics to characterize hepatitis B virus-associated hepatocellular carcinoma.
Li Z; Zhang N; Dong Z; Wang X; Zhou J; Gao J; Yang Y; Li J; Guan F; Zhou Y; Tan Z
Cell Commun Signal; 2024 Apr; 22(1):200. PubMed ID: 38561745
[TBL] [Abstract][Full Text] [Related]
5. Integrating transcriptomics, proteomics, glycomics and glycoproteomics to characterize paclitaxel resistance in breast cancer cells.
Cao L; Zhou Y; Li X; Lin S; Tan Z; Guan F
J Proteomics; 2021 Jul; 243():104266. PubMed ID: 34000456
[TBL] [Abstract][Full Text] [Related]
6. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
[TBL] [Abstract][Full Text] [Related]
7. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
8. Identification of abnormal fucosylated-glycans recognized by LTL in saliva of HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Zhang J; Zhong Y; Zhang P; Du H; Shu J; Liu X; Zhang H; Guo Y; Jia Z; Niu L; Yang F; Li Z
Glycobiology; 2019 Mar; 29(3):242-259. PubMed ID: 30535277
[TBL] [Abstract][Full Text] [Related]
9. Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma.
Liao J; Zhang R; Qian H; Cao L; Zhang Y; Xu W; Li J; Wu M; Yin Z
Biochem Biophys Res Commun; 2012 Apr; 420(2):308-14. PubMed ID: 22425980
[TBL] [Abstract][Full Text] [Related]
10. Altered microheterogeneity at several N-glycosylation sites in OPSCC in constant protein expression conditions.
Dickinson A; Joenväärä S; Tohmola T; Renkonen J; Mattila P; Carpén T; Mäkitie A; Silén S
FASEB Bioadv; 2024 Jan; 6(1):26-39. PubMed ID: 38223202
[TBL] [Abstract][Full Text] [Related]
11. ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface.
Zou X; Lu J; Deng Y; Liu Q; Yan X; Cui Y; Xiao X; Fang M; Yang F; Sawaki H; Sato T; Tan B; Lu X; Feng B; Kuno A; Narimatsu H; Gao C; Zhang Y
Oncogene; 2023 Feb; 42(7):516-529. PubMed ID: 36528750
[TBL] [Abstract][Full Text] [Related]
12. Glycosylation of immunoglobin G in tumors: Function, regulation and clinical implications.
Yang S; Cui M; Liu Q; Liao Q
Cancer Lett; 2022 Nov; 549():215902. PubMed ID: 36096412
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma.
Vogel A; Meyer T; Sapisochin G; Salem R; Saborowski A
Lancet; 2022 Oct; 400(10360):1345-1362. PubMed ID: 36084663
[TBL] [Abstract][Full Text] [Related]
14. N-Glycosylation and Inflammation; the Not-So-Sweet Relation.
Radovani B; Gudelj I
Front Immunol; 2022; 13():893365. PubMed ID: 35833138
[TBL] [Abstract][Full Text] [Related]
15. Trends in the disease burden of HBV and HCV infection in China from 1990-2019.
Yue T; Zhang Q; Cai T; Xu M; Zhu H; Pourkarim MR; De Clercq E; Li G
Int J Infect Dis; 2022 Sep; 122():476-485. PubMed ID: 35724827
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
